Effectiveness of carboplatin vs cisplatin in lung cancer chemo-immunotherapy: A systematic review and meta-analysis [0.03%]
卡铂与顺铂在肺癌化疗免疫治疗中的有效性比较:系统评价和 Meta 分析
Alessandro Leonetti,Giuseppe Maglietta,Marianna Peroni et al.
Alessandro Leonetti et al.
IntroductionChemo-immunotherapy (CT-IT) currently represents the standard therapy for both non-small (NSCLC) and small cell lung cancer (SCLC). However, the differential impact of platinum compounds on immunotherapy outcomes remains to be d...
Hospice admission of cancer patients receiving disease-modifying therapies near the end of life: implications for eligibility criteria [0.03%]
晚期接受疾病修正治疗的癌症患者入住安宁疗护病房的状况及其对纳入标准的意义
Carla Bettini,Andrea Carlini,Laura Fabbri et al.
Carla Bettini et al.
Purpose: This retrospective single-center observational study aimed to describe our experience of admitting patients based on palliative care needs rather than discontinuation of anticancer treatment. ...
Exploring new frontiers: Outcomes and feasibility of a third radiotherapy course in recurrent prostate cancer [0.03%]
探索新领域:复发性前列腺癌第三程放射治疗的有效性和可行性
Costantino Putzu,Federico Mastroleo,Mattia Zaffaroni et al.
Costantino Putzu et al.
Background and purpose: Re-irradiation is increasingly recognized as a viable and safe treatment option for prostate cancer (PCa) local recurrence. The aim of this study is to present the safety profile, feasibility, and ...
Ewing sarcoma of the head and neck region in pediatric patients: A retrospective monoinstitutional series [0.03%]
儿童头颈部尤文肉瘤的单中心回顾性系列研究
Valentina Di Ruscio,Ida Russo,Angela Di Giannatale et al.
Valentina Di Ruscio et al.
Ewing sarcoma (ES) occurs in the head and neck (HN) region in fewer than 10% of cases, presenting distinct therapeutic challenges.We retrospectively reviewed all ES cases diagnosed at our institution from 2000 to 2022.Of 131 patients, 10 (7...
The landscape of artificial intelligence in carbon ion radiotherapy: A scoping review [0.03%]
碳离子放射治疗领域的人工智能现状:系统综述
Giulia Fontana,Sithin Thulasi Seetha,Sara Lillo et al.
Giulia Fontana et al.
Objective: While artificial intelligence (AI) is known to benefit radiotherapy (RT), its applications in carbon ion RT (CIRT) is yet to be surveyed. This scoping review aims to examine the current landscape of AI in CIRT ...
Modern approaches to target tumor heterogeneity: Integrating technology and treatment [0.03%]
针对肿瘤异质性的现代方法:技术与治疗的整合
Amit Kumar,Nisha Manav,Mayank Singh et al.
Amit Kumar et al.
Intratumor heterogeneity (ITH) describes the diversity of cancer cells within a single tumor. This heterogeneity includes differences in the cells' phenotypes, genotypes, and functions. As a result, cancer cells can vary in their morphology...
The impact of bio-psycho-social factors on mental health outcomes in patients with solid tumors [0.03%]
生物心理社会因素对实体肿瘤患者心理健康结局的影响
Raffaela D G Sartori,Davide Dalu,Davide De Francesco et al.
Raffaela D G Sartori et al.
Introduction: The old oncology approach, which considered the clinical and performance status as the most relevant diseases course and well-being indexes, has been recently replaced by a care system also focusing on a per...
Precision animal models of tumors: Advances, challenges and clinical translation [0.03%]
精确的肿瘤动物模型:进展、挑战及临床转化
Zhengyi Wang,Xiaoying Wu
Zhengyi Wang
Preclinical immunotherapy research relies heavily on animal tumor models, which can be broadly classified into four categories: genetically engineered, carcinogen-induced, spontaneous, and humanized transplantation platforms. While these sy...
Outcomes of first-line chemo-immunotherapy in advanced non-squamous NSCLC according to KRAS status: An Italian real-world study [0.03%]
一线化疗联合免疫治疗晚期非鳞NSCLC的临床疗效与KRAS状态的真实世界研究
Alessandro Leonetti,Vanessa Callegari,Fabiana Perrone et al.
Alessandro Leonetti et al.
IntroductionChemo-immunotherapy is the standard frontline treatment of advanced non-squamous non-small cell lung cancer (nsq-NSCLC). Among oncogenic drivers, KRAS mutation accounts for approximately 25% of lung adenocarcinomas, with p.G12C ...
Wen Tang,Min Zhao,Juan He et al.
Wen Tang et al.
Purpose: Natural killer/T-cell lymphoma (NKTCL) is an aggressive lymphoma. Glutathione peroxidase 1 (GPX1) is a prevalent isoform with reported roles in various tumors and prognostic implications. However, GPX1's role in ...